SIREGAR, G.; PARAMESH, R.; KUMAWAT, R.; D, P.; HA, S. A prospective, interventional clinical study to evaluate the safety and efficacy of Liv.52 DS in the management of non-alcoholic fatty liver disease. European Journal of Clinical and Experimental Medicine, [S. l.], v. 19, n. 2, p. 129–136, 2021. DOI: 10.15584/ejcem.2021.2.3. Disponível em: https://journals.ur.edu.pl/ejcem/article/view/11885. Acesso em: 18 jan. 2026.